Crowdly
Add to Chrome
PHY3171 - Cardiovascular physiology and disease - S1 2026
Looking for PHY3171 - Cardiovascular physiology and disease - S1 2026 test answers and solutions? Browse our comprehensive collection of verified answers for PHY3171 - Cardiovascular physiology and disease - S1 2026 at learning.monash.edu.
Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!
PCSK9 inhibitors are most beneficial for patients with:
❌
❌
✅
❌
View this question
What transporter proteins are involved in cholesterol efflux during reverse cholesterol transport?
✅
❌
❌
❌
View this question
Which of the following is a modifiable risk factor that contributes to the development of atherosclerosis?
❌
❌
❌
✅
View this question
In advanced atherosclerotic plaques, defective clearance of dead macrophages leads to:
❌
✅
0%
❌
View this question
3. Which lipoprotein is commonly referred to as "bad" cholesterol?
❌
❌
✅
❌
View this question
What is the effect of a positive inotrope?
❌
❌
✅
❌
View this question
Which molecular mechanism is primarily implicated in doxorubicin-induced cardiotoxicity?
❌
❌
❌
✅
View this question
Anthracyclines, such as doxorubicin, are well known to cause which cardiac complication?
❌
✅
❌
❌
View this question
Which of the following statements about Type II cardiotoxicity is correct?
❌
❌
❌
✅
View this question
Compared to people without cancer, adult cancer survivors have what level of risk for developing cardiovascular disease (CVD)?
✅
❌
❌
❌
View this question